Type to search

ArisGlobal Acquires Boehringer Ingelheim’s Signal Analytics Engine, Bringing Enhanced and Unmatched Pharmacovigilance Capabilities to Life Sciences Industry | Pharmtech Focus
US FDA Approves Jardiance ® (empagliflozin) to Treat Adults with Heart Failure Regardless of Left Ventricular Ejection Fraction | Pharmtech Focus
Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership | Pharmtech Focus